Pharming Group, based in the Netherlands, is one of 20 stocks whose market performance was discussed in the context of biotechs industry growth forecasts for Europe.
3 reports, 2 independent
Updated Aug 5
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pharming Group, based in the Netherlands, is one of 20 stocks whose market performance was discussed in the context of biotechs industry growth forecasts for Europe.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Millennium Management invested in Pharming Group.1 source
Pharming Group's market performance was discussed alongside biotechs industry growth forecasts in the Netherlands.1 source
Keep exploring
The entities involved
-
Pharming Group (Netherlands)
company in Leiden, Netherlands
Nothing else this week.
-
Netherlands
one of the four autonomous countries of the Kingdom of the Netherlands; with territories in the Caribbean
-
Europe
terrestrial continent located in north-western Eurasia
Related events
Coverage
Newest first; wire copies grouped- dailypolitical.com
- Simply Wall St.Pharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024) Revenue: US$93.2m (up 26% from 2Q 2024). Net income: US$4.69m (up from US$1.22m loss in 2Q 2024). Profit margi
- Simply Wall St.High Growth Tech Stocks To Watch In Europe July 2025 As Europe navigates a landscape marked by tentative optimism surrounding an EU-U.S. trade deal and the European Central Bank's steady interest rat